Second bivalent dose allowed for those at high risk from COVID-19
April 20, 2023
Read article
Study looks at long-term response to COVID vaccine in immunocompromised
April 20, 2023
Read article
Community Q&A: primary immunodeficiency & neurological issues with Dr. Stacey Clardy
April 19, 2023
Listen to podcast
Primary immunodeficiency & neurological issues
April 18, 2023
Watch video
Development office
Immune Deficiency Foundation
7550 Teague Road, Suite 220 Hanover, Maryland 21076
If you have questions about making a matching gift, please call 410-321-6647 or email IDF.
Project ECHO clinician series: Steps to diagnosing a PI
April 10, 2023
Watch video
Bold conversations part 2: The roots of medical mistrust among communities of color
April 04, 2023
Listen to podcast
ADMA Biologics
ADMA Biologics is relentlessly committed to creating products for immunodeficient patients at risk for infection.
The Jeffrey Modell Foundation
The Jeffrey Modell Foundation is dedicated to early and precise diagnosis, meaningful treatments, and ultimately cures of primary immunodeficiencies.
Primary Immune Deficiency Treatment Consortium (PIDTC)
The Primary Immune Deficiency (PID) Treatment Consortium (PIDTC) consists of 42 centers in North America whose shared goal is to improve the outcome of patients with rare, life threatening, inherited disorders of the immune system.
